DNAmicBioSystems

Unlocking the potential of in vivo cellular reprogramming

MISSSION

Our patented platform overcomes the significant challenges in cellular reprogramming, such as the safety risks of viral vectors and the inefficiencies of non-viral methods.

Utilizing human proteins and natural cellular communication, we offer a safer, precise, and more effective approach to cell engineering within the body.

We are setting a new standard in cellular therapy and regenerative medicine.

SCIENCE

In-Vivo
‍Cellular
Reprogramming

At DNAmic, we recognize the critical challenges currently impeding progress in cellular reprogramming — the toxicity, inefficiency, and potential risks associated with viral vectors, and the limited delivery capabilities and reduced efficiencies of non-viral systems. Our human-based engineering platform represents a pivotal leap in in-vivo cell engineering and reprogramming, designed to transcend these limitations.

JOIN US

Balancing ambition with openness

We excel in cutting-edge cellular engineering and regenerative medicine, always eager to engage, learn, and grow with fellow pioneers in the biology of cellular therapies.

“ Our platform was designed from the outset with flexibility and broad horizons in mind. Collaboration is at the core of our DNA—we aim to partner with innovators and organizations developing specific therapies. By combining their expertise with our versatile delivery technology, we can accelerate the creation of targeted, effective solutions to address diverse medical challenges.”

Alfonso Fiz

CEO and CO-Founder DNAmic